@FierceMedDev: Touch-sensitive robot arm envisioned, in part, as patient care device. Item | Follow @FierceMedDev
@MarkHFierce: We had a fruitful week at BIO 2013 in Chicago. Check out the highlights. Slideshow | Follow @MarkHFierce
@DamianFierce: In case you missed it over the weekend, Quintiles finally priced its IPO, seeking $790M. News | Follow @DamianFierce
> A prominent venture capital investor sees a challenging future for venture-backed diagnostic companies, due, in part, to their high need for capital and sky-high regulatory uncertainty. Column
> Nasoform, a Menlo Park, CA-based device startup, raised $6 million in new venture funding toward development of a minimally invasive device designed to treat collapsed nasal valves. Story
> Spanish researchers developed a biodegradable coating designed to boost the success rate for dental implants in patients who would otherwise not be able to tolerate the surgery. Item
> Israel plans a major push on April 30 in Taiwan to promote its medical device industry and drum up interest for an exposition on medical innovation planned for June. Item
> Teleflex ($TFX) won 510(k) clearance for a next-generation vascular positioning system. Release
> Medtronic ($MDT) has launched new additions to its Vertex Select reconstruction system, used to treat spinal problems like stenosis, fracture and dislocation. More
> Becton Dickinson's ($BDX) diagnostics unit has partnered with Bruker Daltonics to market the pair's microbial identification technology. News
Biotech News
@FierceBiotech: ICYMI: Johnson & Johnson, Evotec bask in Harvard's breaking diabetes discovery. Story | Follow @FierceBiotech
@JohnCFierce: Union wants AstraZeneca to rethink the big Cambridge move, but I don't see it. A reversal would look like schizophrenia. Article | Follow @JohnCFierce
@RyanMFierce: Shunned Gilead/Bristol-Myers hep C combo may be too good for docs to ignore. Story | Follow @RyanMFierce
> U.K. union makes its case against AstraZeneca's R&D relocation. Item
> Giants team on diabetes as Merck partners with Pfizer on SGLT2 combo. News
> Celgene taps biotech Forma for drugs in hot field of protein homeostasis. Article
> Guidelines for contributing an Industry Voices column to Fierce. Publisher's note
Pharma News
@FiercePharma: ICYMI yesterday: Shunned Gilead/Bristol-Myers hep C combo may be too good for docs to ignore. More | Follow @FiercePharma
> On verge of $13B merger, Valeant and Actavis stop talking. Report
> FDA, Allergan warn of foreign Botox in counterfeit packaging sold to U.S. docs. Article
> Hooters or Nobu, Novartis doc-dinners are kickbacks, feds say. Story
> Jury hits Takeda with $6.5M judgment in first Actos liability case. Article
CRO News
> AMRI inks 5-year CDMO deal with Ono. Story
> Biocon's CRO now largest in India. Article
> Catalent quadruples biologics capacity with new plant. More
> Icon's revenue soars 26% in Q1. Report
Biotech IT News
> AZ helps NHS develop social media app for U.K. market. More
> Medidata's profit up 51% in Q1 compared to last year as customer base grows. Report
> 'Jeff Bezos of bioinformatics' finds capital and customers for startup. Story
> Treato scores $14.5M VC round, tackles social media analytics for pharma. Article
> Mining clinical notes could detect harmful drug reactions earlier. News